Tandem Investment Advisors, Inc. Danaher Corp Transaction History

Tandem Investment Advisors, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 30, 2023	SELL	$233.08 - $265.59 $13,751 - $15,669	-59 Reduced 6.47%	853 $211,000
Q2 2023 Jul 18, 2023	SELL	$224.99 - $256.14 $93,820 - $106,810	-417 Reduced 31.38%	912 $219,000
Q1 2023 Jul 18, 2023	BUY	$239.75 - $277.0 $26,612 - $30,747	111 Added 9.11%	1,329 $335,000
Q4 2022 Feb 06, 2023	BUY	$241.42 - $282.29 $85,462 - $99,930	354 Added 40.97%	1,218 $323,000
Q3 2022 Oct 31, 2022	BUY	$247.06 - $1507.4 $213,459 - $1.3 Million	864 New	864 $223,000
Q2 2022 Sep 14, 2022	SELL	$237.11 - $299.66 $177,358 - $224,145	-748 Closed	0 $0
Q1 2022 May 02, 2022	BUY	$257.27 - $315.76 $16,208 - $19,892	63 Added 9.2%	748 $219,000
Q4 2021 Jan 20, 2022	SELL	$292.08 - $329.01 $4,673 - $5,264	-16 Reduced 2.28%	685 $225,000
Q3 2021 Oct 15, 2021	SELL	$272.21 - $332.43 $20,960 - $25,597	-77 Reduced 9.9%	701 $213,000
Q2 2021 Jul 12, 2021	BUY	$225.08 - $271.69 $175,112 - $211,374	778 New	778 $209,000

2,432

563M

3.94M

4.11M

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $177B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

Get notified when there are updates to the investment portfolio of Tandem Investment Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tandem Investment Advisors, Inc. with notifications on news.